Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 23;12(9):225.
doi: 10.3390/diseases12090225.

Whole Exome Sequencing of Adult Indians with Apparently Acquired Aplastic Anaemia: Initial Experience at Tertiary Care Hospital

Sudhir Mehta  1 , Krishna Mohan Medicherla  2   3 , Sandhya Gulati  1 , Nidhi Sharma  1 , Rabia Parveen  4 , Ashwani Kumar Mishra  4 , Sonal Gupta  2 , Prashanth Suravajhala  3   5
Affiliations

Whole Exome Sequencing of Adult Indians with Apparently Acquired Aplastic Anaemia: Initial Experience at Tertiary Care Hospital

Sudhir Mehta et al. Diseases. .

Abstract

Aplastic anaemia (AA) is a rare hypocellular bone marrow disease with a large number of mutations in the telomerase reverse transcriptase gene (TERT), leading to bone marrow failure. We used our benchmarked whole exome sequencing (WES) pipeline to identify variants in adult Indian subjects with apparently acquired AA. For 36 affected individuals, we sequenced coding regions to a mean coverage of 100× and a sufficient depth was achieved. Downstream validation and filtering to call mutations in patients treated with Cyclosporin A (CsA) identified variants associated with AA. We report four mutations across the genes associated with the AA, TERT and CYP3A5, in addition to other genes, viz., IFNG, PIGA, NBS/NBN, and MPL. We demonstrate the application of WES to discover the variants associated with CsA responders and non-responders in an Indian cohort.

Keywords: aplastic anaemia; exome sequencing; next generation sequencing; systems genomics.

PubMed Disclaimer

Conflict of interest statement

A.K.M. and R.P. work for DNA Xperts and they helped analyze the samples for Telomerase assay and have no conflicts of interests whatsoever.

Similar articles

See all similar articles

References

    1. Levi M., Toh C.H., Thachil J., Watson H.G. Guidelines for the diagnosis and management of Aplastic Anaemia, British Committee for Standards in Haematology. Br. J. Haematol. 2009;145:24–33. doi: 10.1111/j.1365-2141.2009.07600.x. - DOI - PubMed
    1. Shallis R.M., Ahmad R., Zeidan A.M. Aplastic anemia: Etiology, molecular pathogenesis, and emerging concepts. Eur. J. Haematol. 2018;101:711–720. doi: 10.1111/ejh.13153. - DOI - PubMed
    1. Kamat G., Math R.K., Goni D., Balikai G., Savanur A., Mudennavar N., Javaregowda P.K. Use of Cyclosporine A and danazol in treatment of aplastic anemia: A real-world data from a teaching hospital in South India. Asian J. Med. Sci. 2022;13:223–226. doi: 10.3126/ajms.v13i10.45513. - DOI
    1. Li H., Long Z., Wang T., Han B. Stanozolol and Danazol Have Different Effects on Hematopoiesis in the Murine Model of Immune-Mediated Bone Marrow Failure. Front. Med. 2021;8:615195. doi: 10.3389/fmed.2021.615195. - DOI - PMC - PubMed
    1. Townsley D.M., Dumitriu B., Liu D., Biancotto A., Weinstein B., Chen C., Hardy N., Mihalek A.D., Lingala S., Kim Y.J., et al. Danazol Treatment for Telomere Diseases. N. Engl. J. Med. 2016;374:1922–1931. doi: 10.1056/NEJMoa1515319. - DOI - PMC - PubMed

LinkOut - more resources